Source: Pharmabiz

Corium: Corium, Lotus Pharma ink license agreement for innovative Alzheimer's disease treatment Adlarity in multiple markets across Asia

Corium, LLC (Corium), a commercial─stage biopharmaceutical company leading the development and commercialization of novel neuroscience therapies, and Lotus Pharmaceutical, a multinational pharmaceutical

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
250-500
Perry J. Sternberg's photo - President & CEO of Corium

President & CEO

Perry J. Sternberg

CEO Approval Rating

90/100

Read more